Current Assets 更改
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Akebia Therapeutics USD 118.15M 8.55M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Exelixis USD 1.44B 147.16M 2023-09
Immunic USD 65.23M 21.32M 2023-09
Incyte USD 4.65B 242.74M 2023-12
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Xoma USD 34.5M 3.92M 2023-09



Prothena 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.